Carthera receives Orphan Drug Designation from US and EU authorities for carboplatin in malignant glioma menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Breakthrough Status allows for enhanced interaction with FDA and recognizes SonoCloud system as innovative and promising approach for treatment of recurrent glioblastoma Paris, France, June 22, 2022 – Carthera, a French company that designs and develops SonoCloud, an innovative ultrasound-based medical device to tre.